DEM GLOBAL
Global Operations Extending from Türkiye to the World
At Dem Pharmaceuticals, we bring our manufacturing capabilities, product portfolio and industry expertise to different regions around the world. We continue to grow globally through sustainable partnerships across more than 25 countries.
OUR GLOBAL MARKETS
We reach markets around the world through manufacturing capabilities that transcend borders. We establish strong partnerships across different markets and bring our healthcare solutions to wider regions.
Access to Global Markets
We bring our products and solutions to diverse healthcare markets in more than 25 countries.
6 Regions
We conduct our global operations across six different regions, continuously strengthening our international reach.
100+ Licenses
With more than 100 licenses addressing the needs of different markets, we support the global accessibility of our products.
10+ Therapeutic Areas
With a product portfolio spanning more than 10 therapeutic areas, we develop solutions addressing a wide range of healthcare needs.
GLOBAL PRODUCT PORTFOLIO
A Product Portfolio Spanning Diverse Therapeutic Areas
We bring the products we develop and offer across various therapeutic areas together with the needs of global markets.
With our products spanning diverse therapeutic areas—particularly human medicinal products, blood products and oncology—we aim to address the needs of healthcare professionals and patients and create meaningful value.
With our products spanning diverse therapeutic areas—particularly human medicinal products, blood products and oncology—we aim to address the needs of healthcare professionals and patients and create meaningful value.
.svg)
DEM GLOBAL
Local Expertise,
Global Impact
By combining our scientific expertise with strong partnerships, we deliver innovative healthcare solutions to different regions around the world.
25+ Countries
6 Regions
10+ Therapeutic Areas
100+ Marketing Authorizations
GLOBAL PRODUCT PORTFOLIO
The Strategic Center of Our Growth in Europe
In line with Dem Pharmaceuticals’ international growth and globalization strategy, DEM UK began operating in the United Kingdom in 2021. It represents a significant organizational structure that strengthens our strategic presence in Europe.
The United Kingdom’s strong position within the European pharmaceutical industry, advanced healthcare ecosystem and international business connections enable DEM UK to operate as more than a representative office, positioning it as a strategic center that manages growth opportunities across Europe.
In particular, as part of the Global Expansion and Growth Project launched in 2025, DEM UK contributes to Dem Pharmaceuticals’ global growth objectives by identifying and developing new products, licensing opportunities, distribution models, technology partnerships and strategic collaborations across international markets, particularly in Europe.
The United Kingdom’s strong position within the European pharmaceutical industry, advanced healthcare ecosystem and international business connections enable DEM UK to operate as more than a representative office, positioning it as a strategic center that manages growth opportunities across Europe.
In particular, as part of the Global Expansion and Growth Project launched in 2025, DEM UK contributes to Dem Pharmaceuticals’ global growth objectives by identifying and developing new products, licensing opportunities, distribution models, technology partnerships and strategic collaborations across international markets, particularly in Europe.
OUR GLOBAL GROWTH AREAS
Transforming Opportunities into Strategic Partnerships
- We evaluate new product and portfolio opportunities on a global scale.
- We develop out-licensing and in-licensing opportunities.
- We strengthen our distributor and commercial partnership network across Europe.
- We create strategic partnership and business development opportunities.
- We support marketing authorization and market-entry processes for European markets.
- We contribute to the more effective management of our existing projects on an international scale.
DEM UK’s strategic position enables Dem Pharmaceuticals to expand its product, market and partnership ecosystem while establishing Europe as one of the key centers of its global growth journey.
.png)
GLOBAL GROWTH
From Europe to the World
At Dem Pharmaceuticals, our objective is not merely to enter new markets, but to create sustainable global growth by bringing together the right products, the right partners and the right strategic models.
In line with this vision, DEM UK acts as a strategic bridge, connecting opportunities in Europe with Dem Pharmaceuticals’ robust manufacturing, product development and commercial capabilities.
Connecting Dem Pharmaceuticals to Global Opportunities.
In line with this vision, DEM UK acts as a strategic bridge, connecting opportunities in Europe with Dem Pharmaceuticals’ robust manufacturing, product development and commercial capabilities.
Connecting Dem Pharmaceuticals to Global Opportunities.
FLEXIBLE BUSINESS MODELS
Business Models Adapted to Diverse Needs
To address the diverse needs of global markets, we operate through flexible and diversified business models.
By evaluating product, manufacturing, licensing and partnership processes through different models, we develop solutions tailored to the specific requirements of each market and collaboration.
By evaluating product, manufacturing, licensing and partnership processes through different models, we develop solutions tailored to the specific requirements of each market and collaboration.
.svg)
In-House
A model covering the development and manufacturing of products through Dem Pharmaceuticals’ own manufacturing infrastructure, expertise and quality standards.
Co-Development
We develop products and projects together with strategic partners, bringing different areas of expertise and capabilities together within a shared value-creation process.
.svg)
CDMO
By combining product development and manufacturing processes, we provide our partners with integrated solutions covering the different stages of their projects.
.svg)
Portfolio Davestiture
By transferring selected products or portfolio assets to strategic partners, we create opportunities that support portfolio optimization and sustainable growth.
.svg)
Co-Marketing
We develop strategic partnerships for the joint positioning and marketing of products across local and global markets.
.svg)
Global Market Access
By facilitating the import and introduction of finished products into different markets, we expand the reach of our product portfolio across local and global markets.
STRATEGIC PARTNERSHIPS
A Global Network Growing Through Strong Partnerships
We expand our global operations through strong, long-term partnerships.
By bringing together our knowledge, experience and capabilities with those of our partners across different markets, we establish structures that create mutual value while developing new opportunities and sustainable business models around shared objectives.
Through partnerships built on trust, mutual benefit and a long-term perspective, we strengthen our global network while continuously advancing our presence and growth potential across different markets.
By bringing together our knowledge, experience and capabilities with those of our partners across different markets, we establish structures that create mutual value while developing new opportunities and sustainable business models around shared objectives.
Through partnerships built on trust, mutual benefit and a long-term perspective, we strengthen our global network while continuously advancing our presence and growth potential across different markets.
